Transforming Thalassemia Treatment with PK Activation
May 15 2026
Agenda
- 8:00 - 8:05 PM - Opening Remarks - Dr. Asma Al Olama
- 8:05 - 8:30 PM - Thalassemia: From Supportive care to Targeting the root cause - Prof. Ali Taher
- 8:05 - 8:30 PM - ENERGIZE/T Revolutionizing Patient Care - Prof. Khaled Musallam
- 8:30 - 8:45 PM - Role of MDT in Optimizing Patient Care: A view from the Dubai Eye - Prof. Hany Dewedar
- 8:45 - 9:05 PM - TDT/NTDT Challenging Cases - Dr. Amar Lal & Dr. Mozah Al Marshoodi
- 9:05 - 9:25 PM - Panel Discussion - All Faculty
- 9:30 PM - Closing Remarks - Dr. Asma Al Olama
Faculty
.jpg)
Chairman
Dr. Asma Al Olama
President, Emirates Society of Haematology
Consultant Hematologist, Dubai Hospital
United Arab Emirates
Speaker
Prof. Ali Taher
Professor of Medicine in Hematology & Oncology
American University of Beirut Medical Center
Lebanon
Speaker
Dr. Amar Lal
Consultant Hematologist/ Oncologist
Tawam Hospital
UAE
Speaker
Dr. Farrukh Shah
Medical Head, Thalassemia & Sickle Cell Center
Burjeel Medical City
UAE
Speaker
Dr. Hani Dwedar
Head of Medical Department
Thalassemia Center
UAE
Speaker
Dr. Khaled Musallam
Group Chief Research Officer, Deputy CEO and Chief of C&G Therapy and Hematology
Burjeel Medical City
UAE
Speaker
Dr. Mozah Al Marshoudi
Acting Head of Medical Department
Sheikh Khalifa Hospital
UAE
Supported by
